Oppenheimer maintains an 'Outperform' on Cubist Pharmaceuticals (NASDAQ: CBST) price target of $49.00.

Analyst, Christopher Holterhoff, comments after attending ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE